Perrigo Revenue and Competitors
Estimated Revenue & Valuation
- Perrigo's estimated annual revenue is currently $5M per year.
- Perrigo's estimated revenue per employee is $201,000
Employee Data
- Perrigo has 25 Employees.
- Perrigo grew their employee count by 19% last year.
Perrigo's People
Name | Title | Email/Phone |
---|---|---|
1 | Northeast Director Sales | Reveal Email/Phone |
2 | Senior Manage Financial and Asset Management | Reveal Email/Phone |
3 | President | Reveal Email/Phone |
4 | Sales Representative | Reveal Email/Phone |
5 | Inside Sales Associate | Reveal Email/Phone |
Perrigo Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.9M | 120 | 28% | N/A | N/A |
#2 | $1105.9M | 5502 | 3% | N/A | N/A |
#3 | $47M | 234 | 26% | N/A | N/A |
#4 | $9.2M | 46 | 5% | N/A | N/A |
#5 | $10192.5M | 44584 | 6% | N/A | N/A |
#6 | $6M | 27 | 8% | N/A | N/A |
#7 | $110.1M | 335 | -26% | N/A | N/A |
#8 | $8.8M | 39 | 8% | N/A | N/A |
#9 | $21.3M | 42 | -52% | N/A | N/A |
#10 | $27.7M | 117 | 3% | N/A | N/A |
What Is Perrigo?
Our anchor product lines of ITT Pure-Flo, PBM valves, Fristam Pumps, Steridose mixers, Anderson Instruments, Turck, SPX-Flow, and StoneL control products along with our team’s decades of experience makes Perrigo Inc. the premier distributor of equipment in the BioPharm industry. Our quick turnaround times on quotes, orders, and information while providing the customer with the service, knowledge and help they need is what sets us apart from all the rest. Customer service is our top priority, and we try to prove that in everything we do.
keywords:N/AN/A
Total Funding
25
Number of Employees
$5M
Revenue (est)
19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9.2M | 25 | -7% | N/A |
#2 | $2.1M | 25 | 25% | N/A |
#3 | N/A | 25 | 4% | N/A |
#4 | $8.8M | 25 | 0% | N/A |
#5 | $7.5M | 25 | -7% | N/A |